The most recent trading session ended with Medtronic (MDT) standing at $80.74, reflecting a -1.05% shift from the previouse trading day's closing. The stock's performance was ahead of the S&P 500 ...

The latest positive data from MDT’s Optimize PRO clinical study for Evolut TAVR is likely to boost the company’s business and help increase the stock’s price. Meanwhile, MDT currently has a ...

I remain bullish on this stock and reiterate my "Buy" rating, hoping for a better 2025. I initiated coverage of the MDT stock in late October 2023 with a "Buy" rating, which I then confirmed twice.

Medtronic MDT closed at $79.99 in the last trading session ... While this has, to some extent, led to a boost in the stock prices of several MedTech players, the Fed’s conservative approach ...